Brain mechanisms link foods to rising obesity rates

February 07, 2012

CINCINNATI--An editorial authored by University of Cincinnati (UC) diabetes researchers to be published in the Feb. 7, 2012, issue of the journal Cell Metabolism sheds light on the biological factors contributing to rising rates of obesity and discusses strategies to reduce body weight.

According to the U.S. Centers for Disease Control, about one-third of U.S. adults are obese, a number that continues to climb.

"While we don't usually think of it this way, body weight is regulated. How much we weigh is influenced by a number of biological systems, and this is part of what makes it so hard for people to lose weight and keep it off," says Randy Seeley, PhD, Donald C. Harrison Endowed Chair, director of the Cincinnati Diabetes and Obesity Center and author on the paper along with Karen Ryan, PhD, an assistant professor in endocrinology, diabetes and metabolism at UC.

"To understand the obesity epidemic, we must figure out how our environment alters these biological systems to encourage weight gain."

Seeley says a big part of the environment that encourages weight gain is the availability and consumption of calorically dense, high-fat foods--in particular, what we eat can alter the brain regions that regulate body weight.

"Leptin is a key hormone that is secreted from fat tissue, or adipose tissue, and its main function is to inhibit appetite," Seeley says. "Via a number of molecular mechanisms, eating a high-fat diet reduces the actions of leptin in the brain. This miscommunication can lead to increased food intake and weight gain."

"Evolutionary speaking, we are designed to want to eat foods that are high in fat and gain weight because it made it easier to survive times when food was not available," he continues. "However, that is no longer a real concern since food is almost always available, but we still have a biological desire to eat these calorically dense foods. So, how do we intervene and change this drive?"

Seeley says there are several key points in successful therapeutic interventions for the population facing social, financial and health consequences of obesity.

"The key issue is to find ways to take these biological systems that usually make it hard to lose weight and make them work for us to so that it is easier for obese individuals to lose weight," he says. "As we understand the molecular interaction between what we eat and these brain circuits that regulate our body weight, we can design interventions that reduce the body weight that our bodies defend. This will mean that people trying to lose weight would be able to work with their biology rather than trying to use will power to overcome their biology that pushes them back to their obese state. Such an endeavor will ultimately require a wide range of scientists from different fields to reduce both the human and monetary costs of the obesity epidemic."
-end-


University of Cincinnati Academic Health Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.